Presence of sarcopenia identifies a special group of lean NAFLD in middle-aged and older people

NAFLD‐related gene polymorphisms and all‐cause and cause‐specific mortality in an Asian population: the Shanghai Changfeng Study

(2022) Mingfeng Xia et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine

(2021) Deyang Yu et al.   Cell Metabolism

Serum Amino Acids Patterns and 4-Year Sarcopenia Risk in Community-Dwelling Chinese Older Adults

(2021) Suey S.Y. Yeung et al.   GERONTOLOGY

Enterically derived high-density lipoprotein restrains liver injury through the portal vein

(2021) Yong-Hyun Han et al.   SCIENCE

Biomarker Discovery in Atherosclerotic Diseases Using Quantitative Nuclear Magnetic Resonance Metabolomics

(2021) Shuai Ma et al.   Frontiers in Cardiovascular Medicine

Lipoprotein subfractions in patients with sarcopenia and their relevance to skeletal muscle mass and function

(2021) Hui Gong et al.   EXPERIMENTAL GERONTOLOGY

Branched-Chain Amino Acid Catabolism Promotes Thrombosis Risk by Enhancing Tropomodulin-3 Propionylation in Platelets

(2020) Yanyan Xu et al.   CIRCULATION

Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016

(2020) B. Zou et al.   JOURNAL OF INTERNAL MEDICINE

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis

(2020) Qing Ye et al.   Lancet Gastroenterology & Hepatology

Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection

(2020) Guoxiang Xie et al.   BMC Medicine

Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study

(2020) Ming-Feng Xia et al.   CLINICAL NUTRITION

Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR-based lipoprotein profiling

(2020) Mingfeng Xia et al.   JOURNAL OF HEPATOLOGY

The PNPLA3 rs738409 C>G variant influences the association between low skeletal muscle mass and NAFLD: the Shanghai Changfeng Study

(2019) Ming-Feng Xia et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Epidemiology of chronic liver diseases in the USA in the past three decades

(2019) Zobair M Younossi et al.   GUT

Sarcopenia

(2019) Alfonso J Cruz-Jentoft et al.   LANCET

Sarcopenia and fatty liver disease

(2019) Jung A. Kim et al.   Hepatology International

The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease

(2019) Yiwen Shi et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

(2018) Chris Estes et al.   JOURNAL OF HEPATOLOGY

Quantitative Lipoprotein Subclass and Low Molecular Weight Metabolite Analysis in Human Serum and Plasma by 1H NMR Spectroscopy in a Multilaboratory Trial

(2018) Beatriz Jiménez et al.   ANALYTICAL CHEMISTRY

Non-alcoholic fatty liver disease – A global public health perspective

(2018) Zobair M. Younossi   JOURNAL OF HEPATOLOGY

Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis

(2017) Rahima A. Bhanji et al.   HEPATOLOGY

Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis

(2017) Bo Kyung Koo et al.   JOURNAL OF HEPATOLOGY

Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease

(2016) S. Petta et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Relationship Between Low Relative Muscle Mass and Coronary Artery Calcification in Healthy AdultsSignificance

(2016) Byung-Joon Ko et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

(2016) Zobair M. Younossi et al.   HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Sarcopenia and mortality among a population-based sample of community-dwelling older adults

(2015) Justin C. Brown et al.   Journal of Cachexia Sarcopenia and Muscle

Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia

(2014) Liang-Kung Chen et al.   Journal of the American Medical Directors Association

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

(2014) Hannele Yki-Järvinen   Lancet Diabetes & Endocrinology

Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study

(2013) Ho Cheol Hong et al.   HEPATOLOGY

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

(2011) Vincent Wai-Sun Wong et al.   GUT

Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method

(2011) Ming-Feng Xia et al.   Obesity

Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular Medicine

(2008) James H. Stein et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY